- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic kidney disease in Type 2 diabetes
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 850KB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 211KB)
Finerenone – March 2023
Finerenone: Tablet 10 mg, Tablet 20 mg; Kerendia®
Last updated
30 June 2023